Search - tctmd.com

Displaying 201 - 220 of 647

Sort: Relevancy | Date

DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short

News Daily News

DNRs Muddy Waters in Acute MI Care as Palliative Services Fall Short

Yael L. Maxwell

October 27, 2021

COVID-19: TCTMD’s Dispatch for October Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

October 25, 2021

Good TAVI Outcomes in Young Patients, but Population Is Unique

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

October 15, 2021

For Cardiac Tumors, CMR Proves Powerful for Predicting Mortality

News Daily News

For Cardiac Tumors, CMR Proves Powerful for Predicting Mortality

Yael L. Maxwell

September 29, 2021

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

September 28, 2021

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

Long-term Anticoagulation After Unprovoked VTE: New Insights

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

September 13, 2021

Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Presentation ESC 2021

Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Presenter: Renato D. Lopes

August 31, 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

News Conference News ESC 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

August 28, 2021

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

August 20, 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

August 19, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 3

August 15, 2021

Early Recurrent Events After Acute MI: Clues to Origins Hint at Solutions

News Daily News

Early Recurrent Events After Acute MI: Clues to Origins Hint at Solutions

August 10, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 2

August 08, 2021

VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD

News Conference News HRS 2021

VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD

July 29, 2021

Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis

News Daily News

Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis

July 22, 2021

Making the Case for Sex-Specific CVD Guidelines

News Daily News

Making the Case for Sex-Specific CVD Guidelines

July 08, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.